Basiliximab en el tratamiento del rechazo celular agudo resistente a los corticoides postrasplante hepático

[1]  J. Castroagudín,et al.  Calcineurin inhibitors in liver transplantation: to be or not to be. , 2011, Transplantation proceedings.

[2]  I. Marino,et al.  Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. , 2006, The Journal of surgical research.

[3]  B. Portmann,et al.  Anti-interleukin 2 receptor antibodies and mycophenolate mofetil for treatment of steroid-resistant rejection in adult liver transplantation. , 2005, Transplantation Proceedings.

[4]  C. Wai,et al.  Treatment of steroid-resistant acute liver transplant rejection with basiliximab. , 2005, Transplantation proceedings.

[5]  M. Rela,et al.  Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transpland recipients: a preliminary experience1 , 2003, Transplantation.

[6]  J. McCall,et al.  The natural history of acute histologic rejection without biochemical graft dysfunction in orthotopic liver transplantation: A systematic review , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  A. González-Quintela,et al.  Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus. , 2002, Transplantation proceedings.

[8]  S. Tomé,et al.  Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. , 2002, Transplantation proceedings.

[9]  P. Neuhaus,et al.  Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double‐blind randomized placebo‐controlled trial , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  H. Wolters,et al.  Basiliximab in the therapy of acute rejection after organ transplantation. , 2001, Transplantation proceedings.

[11]  J. Neuberger.  Incidence, timing, and risk factors for acute and chronic rejection. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  B. Hepkema,et al.  Incidence, risk factors, and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[13]  G. Klintmalm,et al.  OKT3 rescue for steroid-resistant rejection in adult liver transplantation. , 1993, Transplantation.